Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile

Date: July 28, 2016
Pages: 136
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SDDFD8807C2EN
Leaflet:

Download PDF Leaflet

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile
Summary

Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing of therapeutic solutions. The company offers a wide range of medicines, vaccines and innovative therapeutic solutions. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and animal health products comprising anti-infectives, anti-parasitics, vaccines and other products. Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals and supplements. It has operations across Europe, North America, Latin America, Asia-Pacific and Africa & Middle East. Sanofi is headquartered in Paris, France.

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Sanofi, Medical Equipment, Deals By Year, 2010 to YTD 2016
Sanofi, Medical Equipment Deals By Type, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Region, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Market, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals Summary, 2010 to YTD 2016
Sanofi, Medical Equipment, Deal Details
Asset Purchase
Sanofi-Aventis Acquires Inhalation Assets From Siegfried
Venture Financing
Portal Instruments Raises USD25 Million in Series B Financing
Portal Instruments Raises USD11 Million in Series A Venture Financing
Partnerships
Abiogen Pharma Enters Into Licensing Agreement With Genzyme
CMIC Signs An Agreement With Genzyme
Google Life Sciences Enters into Agreement with Sanofi
Veracyte Enters into Co-Promotion Agreement with Genzyme
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System
Genzyme Extends Co-Promotion Agreement with Veracyte
Sanofi Enters into Co-Development Agreement with Medtronic
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis
Genzyme Enters Into Co-Marketing Agreement With Veracyte
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform
Institut Pasteur Korea Enters Into Co-Development Agreement With Sanofi-Aventis Korea
Voluntis and CERITD Enters Into Co-Development Agreement With Sanofi
Sanofi-Aventis Enters Into Distribution Agreement With Spineart
AgaMatrix Signs Agreement With Sanofi-Aventis
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
F. Hoffmann-La Roche Enters Into Licensing Agreement With Genzyme
Equity Offering
Alnylam Pharma to Raise USD61.5 Million in Private Placement of Shares
Debt Offering
Sanofi Prices Public Offering of 1.5% Notes Due 2025 for USD850 Million
Sanofi Prices Public Offering of Notes Due 2019 for USD850 Million
Sanofi Prices Public Offering of 1.75% Notes Due 2026 for USD1.64 Billion
Sanofi Prices Public Offering of 1.125% Notes Due 2022 for USD1.31 Billion
Sanofi Prices Public Offering Of Bonds Due 2023 For US$1.35 Billion
Sanofi Prices Public Offering Of Bonds Due 2020 For US$1.3 Billion
Sanofi Completes Public Offering Of Notes Due 2018 For US$1.5 Billion
Sanofi Completes Public Offering Of Notes Due 2017 For US$960 Million
Sanofi Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million
Genzyme Completes Private Placement Of 5% Notes For US$500 Million
Genzyme Completes Private Placement Of 3.6% Notes For US$500 Million
Asset Transactions
Nichi-iko Pharma To Acquire Business From Sanofi-Aventis
Genzyme Completes Sale Of Its Diagnostic Business To Sekisui Chemical
Acquisition
Sanofi-Aventis To Acquire Minority Stake In Shantha Biotechnics For US$123 Million
L'Oreal Plans To Sell Its Stake In Sanofi
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb
Sanofi Completes Acquisition Of Pluromed
Sanofi-Aventis Completes Acquisition Of Genzyme
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme
Sanofi - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium
Aug 31, 2015: Sanofi To Collaborate With Google Life Sciences To Improve Diabetes Health Outcomes
Jul 15, 2015: Sanofi Announces New, Global Business Unit Structure To Drive Future Growth
Financial Announcements
Apr 29, 2016: Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates
Feb 09, 2016: Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance
Jul 30, 2015: Sanofi delivers solid sales and business EPS(1) growth in Q2 2015
Apr 30, 2015: Sanofi Delivers Q1 2015 Business Eps Growth Of 2.6% At Cer And 12.8% On A Reported Basis
Feb 05, 2015: Sanofi delivers Business EPS growth of 7.3% at CER in 2014
Corporate Communications
May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
Mar 29, 2016: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research
Mar 10, 2016: Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer
Nov 18, 2015: Xavier Darcos appointed President of the Sanofi Espoir Foundation
May 26, 2015: Sanofi Appoints Suresh Kumar To The Executive Committee And Executive Vice President, External Affairs
May 15, 2015: Sanofi Announces Departure Of Chief Strategy Officer
Mar 06, 2015: Sanofi Appoints Robert Castaigne As Audit Committee Chairman
Feb 19, 2015: Sanofi Appoints Olivier Brandicourt As Chief Executive Officer
Feb 11, 2015: Sanofi To Layoff 100 Employees In Massachusetts
Government and Public Interest
Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
Product News
Aug 19, 2015: Paxman Cold Cap Chemotherapy Hair Loss Prevention Investigational Device - Clinical Trials Expand to Second Dallas Oncology Center
Other Significant Developments
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium
Apr 19, 2016: Sanofi Invests €300 Million in its Biologics Site in Belgium to Develop its Monoclonal Antibodies Portfolio
Sep 16, 2015: Sanofi's CSR Achievements Recognized In The Dow Jones Sustainability Indices
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sanofi, Medical Equipment, Key Facts, 2015
Sanofi, Medical Equipment, Deals Summary, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Year, 2010 to YTD 2016
Sanofi, Medical Equipment Deals By Type, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Region, 2010 to YTD 2016
Sanofi, Deals By Market, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals Summary, 2010 to YTD 2016
Sanofi-Aventis Acquires Inhalation Assets From Siegfried
Portal Instruments Raises USD25 Million in Series B Financing
Portal Instruments Raises USD11 Million in Series A Venture Financing
Abiogen Pharma Enters Into Licensing Agreement With Genzyme
CMIC Signs An Agreement With Genzyme
Google Life Sciences Enters into Agreement with Sanofi
Veracyte Enters into Co-Promotion Agreement with Genzyme
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System
Genzyme Extends Co-Promotion Agreement with Veracyte
Sanofi Enters into Co-Development Agreement with Medtronic
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis
Genzyme Enters Into Co-Marketing Agreement With Veracyte
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Curetis Enters Into Agreement With Sanofi Pasteur For Unyvero Platform
Institut Pasteur Korea Enters Into Co-Development Agreement With Sanofi-Aventis Korea
Voluntis and CERITD Enters Into Co-Development Agreement With Sanofi
Sanofi-Aventis Enters Into Distribution Agreement With Spineart
AgaMatrix Signs Agreement With Sanofi-Aventis
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
F. Hoffmann-La Roche Enters Into Licensing Agreement With Genzyme
Alnylam Pharma to Raise USD61.5 Million in Private Placement of Shares
Sanofi Prices Public Offering of 1.5% Notes Due 2025 for USD850 Million
Sanofi Prices Public Offering of Notes Due 2019 for USD850 Million
Sanofi Prices Public Offering of 1.75% Notes Due 2026 for USD1.64 Billion
Sanofi Prices Public Offering of 1.125% Notes Due 2022 for USD1.31 Billion
Sanofi Prices Public Offering Of Bonds Due 2023 For US$1.35 Billion
Sanofi Prices Public Offering Of Bonds Due 2020 For US$1.3 Billion
Sanofi Completes Public Offering Of Notes Due 2018 For US$1.5 Billion
Sanofi Completes Public Offering Of Notes Due 2017 For US$960 Million
Sanofi Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million
Genzyme Completes Private Placement Of 5% Notes For US$500 Million
Genzyme Completes Private Placement Of 3.6% Notes For US$500 Million
Nichi-iko Pharma To Acquire Business From Sanofi-Aventis
Genzyme Completes Sale Of Its Diagnostic Business To Sekisui Chemical
Sanofi-Aventis To Acquire Minority Stake In Shantha Biotechnics For US$123 Million
L'Oreal Plans To Sell Its Stake In Sanofi
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb
Sanofi Completes Acquisition Of Pluromed
Sanofi-Aventis Completes Acquisition Of Genzyme
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme
Sanofi, Key Competitors
Sanofi, Key Employees
Sanofi, Subsidiaries

LIST OF FIGURES

Sanofi, Medical Equipment, Deals by Type, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Year, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Region, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Market, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Year, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals by Type, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals By Region, 2010 to YTD 2016
Sanofi, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: